-
DAC Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dac
EGAC50000000694
-
single cell RNA seq
Dataset
EGAD50000002022
-
SIA Subtyping Shallow Whole Genome Sequencing (sWGS)
Dataset
EGAD50000001760
-
HOVON152 Trial Targetted Sequencing
Dataset
EGAD50000002093
-
Germline Pan-cancer Lynch syndrome sequencing dataset from India
Dataset
EGAD50000002088
-
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
Dataset
EGAD50000001857
-
Pacbio_methylation_cases
Dataset
EGAD00010002807
-
RNA-seq for 8 samples
Dataset
EGAD50000001789
-
ATAC-seq for 2 samples
Dataset
EGAD50000001791
-
Long-read whole-genome sequencing dataset of aplastic anemia
Dataset
EGAD50000002257